UFP Technologies, Inc.
UFPT Healthcare Medical Devices
UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024.
- Revenue
- +11.6%
- EPS
- +25.6%
- Free cash flow
- −35.8%
- Total debt
- −40.2%
Quarter to September 2026, against a year earlier
Follow UFPT
Alert me
UFP Technologies, Inc. (UFPT) Revenue growth
UFP Technologies, Inc.'s revenue growth over the twelve months to 30 September 2026 was 8.62%, down 10.9 percentage points from fiscal 2025 (19.5%). Over the past ten years it has ranged from −9.58% (fiscal 2020) to 71.5% (fiscal 2022); the current reading is higher than 73% of that period. That is below the Medical Devices industry median of 10.4% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 19.5% | (6.58) |
| FY2024 | 26.1% | 13.00 |
| FY2023 | 13.1% | (58.40) |
| FY2022 | 71.5% | 56.46 |
| FY2021 | 15.0% | 24.60 |
| FY2020 | −9.58% | (13.74) |
| FY2019 | 4.16% | (24.66) |
| FY2018 | 28.8% | 27.65 |
| FY2017 | 1.17% | (4.07) |
| FY2016 | 5.24% | 5.57 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 11.6% | (3.50) |
| Jun 2026 | 15.1% | 10.98 |
| Mar 2026 | 4.09% | 0.73 |
| Dec 2025 | 3.36% | (3.11) |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| BFLY Butterfly Network, Inc. compare | 39.4% |
| ESTA Establishment Labs Holdings Inc. compare | 38.6% |
| TMDX TransMedics Group, Inc. compare | 28.5% |
| AXGN AxoGen, Inc. compare | 24.3% |
| NVCR NovoCure Limited compare | 12.9% |
| UFPT UFP Technologies, Inc. | 8.62% |
| INSP Inspire Medical Systems, Inc. compare | −0.19% |
| NEOG Neogen Corporation compare | −0.33% |
| ALMR Alamar Biosciences, Inc. compare | — |
| Medical Devices industry median | 10.4% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on UFPT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement